Incyte Corporation officer Thomas Tray filed a Form 144 notice of proposed sale of 610 shares of Incyte common stock on November 3, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.

Key Highlights

  • Proposed seller: Thomas Tray, identified as an officer of Incyte Corporation.
  • Shares to be sold: 610 shares of Incyte common stock, with an aggregate market value of $73,224.40, according to the filing.
  • Shares outstanding: The filing lists 203,832,492 shares of common stock outstanding.
  • Source of shares: 210 shares acquired via the Employee Stock Purchase Plan on April 30, 2026, and 400 shares from Restricted Stock Units acquired on July 2, 2025.
  • Approximate sale date: November 3, 2026, through NASDAQ.
  • Rule 10b5-1 plan: The filing indicates a plan adoption or instruction date of July 31, 2026.
  • Prior sales: The filing reports nothing to disclose for securities sold during the past 3 months.

Thomas Tray's Proposed Share Sale at Incyte Corporation

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Thomas Tray, an officer of Incyte Corporation (NASDAQ:INCY), provided notice of a proposed sale of 610 shares of the company's common stock. The filing lists an aggregate market value of $73,224.40 for the proposed transaction, with the approximate date of sale noted as November 3, 2026. The named broker for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

The filing identifies two separate lots of securities as the source of the shares to be sold. The first lot consists of 210 shares acquired on April 30, 2026, through the Employee Stock Purchase Plan from the issuer, with cash payment noted. The second lot consists of 400 shares acquired on July 2, 2025, via Restricted Stock Units, also from the issuer. The filing states no securities of Incyte were sold by Tray during the past three months.

The filing notes a Rule 10b5-1 plan adoption or instruction date of July 31, 2026. By signing the notice, the filer represents, as of that plan adoption date, that he did not know of any material adverse information regarding the current and prospective operations of Incyte Corporation that had not been publicly disclosed, as stated in the form's attestation language.

What Was Disclosed

Incyte officer Thomas Tray filed a Form 144 on November 3, 2026, disclosing a proposed sale of 610 common shares with an aggregate market value of $73,224.40, sourced from an Employee Stock Purchase Plan and Restricted Stock Units, under a Rule 10b5-1 plan adopted July 31, 2026.